Serial intravascular ultrasonographic measurements after implantation of biodegradable polymer-coated stents in porcine coronary arteries

Coronary Artery Disease

Volumn 14, Issue 5, 2003, Pages 409-412

  Fröhlich, Georg ^a   Strehblow, Christoph ^a   Sperker, Wolfgang ^a   Yahya, Nabil ^a   Shirazi, Maryam ^a   Hevesi, Akos ^b   Garamvölgyi, Rita ^b   Hadjiev, Janaki ^b   Scherzer, Thomas ^a   Glogar, Dietmar ^a   Gyöngyösi, Mariann ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b SZENT ISTVÁN UNIVERSITY   (Hungary)

Author keywords

Biodegradable polymer coating; Coronary stent; Drug eluting stent; In stent restenosis; Intimal hyperplasia

Indexed keywords

METAL; POLYMER;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BIODEGRADABILITY; CAROTID ARTERY; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY STENT; DRUG DELIVERY SYSTEM; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; INTRAVASCULAR ULTRASOUND; MATERIAL COATING; METAL IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; SWINE;

ANIMALS; CORONARY ANGIOGRAPHY; CORONARY VESSELS; HYPERPLASIA; PILOT PROJECTS; STENTS; SWINE; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0042739067     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200308000-00009     Document Type: Article

References (8)

1. Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003; 107:381-383.
2. Tanabe K, Serruys PW, Grube E, Smits PC, Selbach G, van der Giesse WJ, et al. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation. Circulation 2003; 10:559-564.
3. Virmani R, Kolodgie FD, Farb A, Lafont A. Drug eluting stents: are human and animal studies comparable? Heart 2003; 89:133-138.
4. Van der Giessen WJ, Lincoff M, Schwartz RS, van Beusekim HM, Serruys PW, Holmes DR, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94:1690-1697.
5. Strehblow C, Gyöngyösi M, Sperker W, Shirazi M, Windberger U, Pugatsch T, et al. Usefulness of intravascular ultrasound-guided histological measurements after stenting in porcine coronary artery. Coronary Artery Dis 2002; 13:291-294.
6. Finkelstein A, McClean D, Kar S, Takizawa K, Varghese K, Baek N, et al. Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation 2003; 107:777-784.
7. Lee SH, Szinai I, Carpenter K, Katsarava R, Jokhadze G, Chu CC, et al. In-vivo biocompatibility evaluation of stents coated with a new biodegradable elastomeric and functional polymer. Coronary Artery Dis 2002; 13:237-241.
8. Schwartz RS, Edelman ER, Carter A, Chronos N, Rogers C, Robinson KA, et al. Drug-eluting stents in preclinical studies. Circulation 2002; 106:1867-1873.